Cargando…
Correction: Need and value of targeted immunosuppressive therapy in giant cell arteritis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966561/ https://www.ncbi.nlm.nih.gov/pubmed/35351809 http://dx.doi.org/10.1136/rmdopen-2021-001652corr1 |
Ejemplares similares
-
Need and value of targeted immunosuppressive therapy in giant cell arteritis
por: Sandovici, Maria, et al.
Publicado: (2022) -
Correction: Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study
por: Jamilloux, Yvan, et al.
Publicado: (2013) -
Correction to: Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study
por: Brekke, L. K., et al.
Publicado: (2018) -
Correction to: Thoracic endovascular repair of a rare case of leaking aortic arch intramural hematoma secondary to Giant cell arteritis
por: Salaskar, Abhijit, et al.
Publicado: (2020) -
Correction: Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
Publicado: (2023)